Close Menu

NEW YORK – Finnish genetic testing firm Negen has rolled out a pharmacogenomics panel designed to help guide decisions in treating patients with SARS-CoV-2. The Helsinki-based firm is making its panel available for free to people who already have been genotyped by consumer genomics services or biobanks.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.